Neuroprotective effects of chronic administration of levetiracetam in a rat model of diabetic neuropathy
Articles > Article · 2016
Authors: Oytun Erbas, Fatih OLTULU, Mustafa Yilmaz, Altuğ YAVAŞOĞLU, Dilek TAŞKIRAN
DIABETES RESEARCH AND CLINICAL PRACTICE, Journal Indexed in SCI Expanded, International, 2016, vol 114, pp 106-116
DOI: 10.1016/j.diabres.2015.12.016
Summary
Objective: Diabetic neuropathy (DNP) is a frequent and serious complication of diabetes mellitus (DM) that leads to progressive and length-dependent loss of peripheral nerve axons. The purpose of the present study is to assess the neuroprotective effects of levetiracetam (LEV) on DNP in a streptozotocin (STZ)-induced DM model in rats.